Literature DB >> 16914716

Treatment of recurrent erythema nodosum leprosum with infliximab.

William R Faber, Annigje J Jensema, Wouter F M Goldschmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16914716     DOI： 10.1056/NEJMc052955

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  [Disseminated erythema nodosum].

Authors:  R Mota; D Bruch-Gerharz; R Kruse; U R Hengge
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

Review 2.  [Cytokine regulation and pain. Results of experimental and clinical research].

Authors:  N Uçeyler; C Sommer
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

Review 3.  Leprosy in the 21st century.

Authors:  Cassandra White; Carlos Franco-Paredes
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 4.  Leprosy and the human genome.

Authors:  Elizabeth A Misch; William R Berrington; James C Vary; Thomas R Hawn
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

5.  Case Report: A Case Series of Immunobiological Therapy (Anti-TNF-α) for Patients With Erythema Nodosum Leprosum.

Authors:  Ana Flávia Moura Mendes; Ciro Martins Gomes; Patrícia Shu Kurizky; Mayra Ianhez
Journal:  Front Med (Lausanne)       Date:  2022-06-24

6.  Biologics in Leprosy: A Systematic Review and Case Report.

Authors:  Anna L Cogen; Eglantine Lebas; Barbara De Barros; James P Harnisch; William R Faber; Diana N Lockwood; Stephen L Walker
Journal:  Am J Trop Med Hyg       Date:  2020-05       Impact factor: 2.345

7.  Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis.

Authors:  Kathryn E McDougal; M Daniele Fallin; David R Moller; Zhimin Song; David J Cutler; Lori L Steiner; Garry R Cutting
Journal:  J Invest Dermatol       Date:  2009-02-19       Impact factor: 8.551

8.  Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation of a latent infection?

Authors:  Roberta Vilela Lopes; Claudia Barros Ohashi; Luiza Helena Cavaleiro; Rosana de Britto Pereira Cruz; Rossana Ruth Garcia da Veiga; Mário Fernando Ribeiro Miranda; Gilberto Toshimitsu Yoshikawa
Journal:  Clin Rheumatol       Date:  2009-03-04       Impact factor: 2.980

Review 9.  Current approaches and future directions in the treatment of leprosy.

Authors:  Sophie M Worobec
Journal:  Res Rep Trop Med       Date:  2012-08-01

10.  Etanercept in erythema nodosum leprosum.

Authors:  Julia Rocha Silva Santos; Dâmia Leal Vendramini; José Augusto da Costa Nery; João Carlos Regazzi Avelleira
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.